Latest News and Press Releases

Waltham, MA, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., and MD Anderson Cancer Center had a unique study published in Clinical Cancer Research, a peer reviewed publication of the...

Waltham, MA, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. will be presenting the company’s cutting edge long-RNAseq platform at this year’s American Society of Exosomes and...

Baltimore, MD and Boston, MA, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics (ExoDx) and Chesapeake Urology announced today that they have initiated a new evidence development study to...

Waltham, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, today announced the launch of the MedOncAlyzer 170, the first liquid biopsy pan-cancer...

Waltham, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a leader in the liquid biopsy market, announced that it has received ISO 13485 certification for both its USA and German...

Waltham, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, announced today that it has moved into a new worldwide headquarters and clinical...

Waltham, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, announced today that it has moved into a new worldwide headquarters and clinical...

Waltham, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics Inc., a leader in the liquid biopsy market, today announced the close of its $30 million Series C financing, led by insiders,...

Boston, MA, June 22, 2017 (GLOBE NEWSWIRE) -- John Boyce, President and CEO of Exosome Diagnostics Inc., a leader in the liquid biopsy space, presented a talk entitled “The True Liquid Biopsy”...

Cambridge, MA, June 01, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. introduces its Exosome Dx Depletion Enrichment (EDDE) to members of ASCO at the upcoming annual meeting.  The patented EDDE...